Navigation Links
Coronary Disease Dulls Cognitive Skills
Date:7/23/2008

Large study found the longer person had heart trouble, the worse their performance

WEDNESDAY, July 23 (HealthDay News) -- Men and women suffering from coronary heart disease seem to fare worse on measures of cognitive function.

And the longer the person had had heart disease, the worse the performance in such mental processes as reasoning, vocabulary and verbal fluency, according to a study in the July 23 issue of the European Heart Journal.

The research, however, had some limitations that may affect its value.

"It's a very well-designed study with a very large number of individuals, so they were able to appreciate small differences in cognitive function," said Dr. Kathryn J. Kotrla, chairwoman of psychiatry and behavioral science for the Texas A&M Health Science Center College of Medicine. "But they didn't control for some key variables such as alcohol and tobacco, which are well-known to impact blood vessel disease. Also depression, which is linked to both coronary heart disease and cognitive functioning."

"This makes the study tantalizing but incomplete," Kotrla added.

Previous studies have given conflicting results regarding the relationship between heart disease and cognitive function. Some have found coronary heart disease (CHD) to be a risk factor, while others have not.

According to the researchers, from University Hospital London and INSERM in France, this is the first large study to look at the association. And, previously, research had focused more on cerebrovascular disease (which includes stroke) rather than just CHD, even though CHD is responsible for most cardiovascular disease. That prior research had found a strong relationship between cerebrovascular disease and cognitive deficit and dementia.

The researchers looked at almost 6,000 British civil servants, aged 35 to 55 at the beginning of the project, taking part in a long-term study.

Bo
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Use of certain lipid measures not more effective in predicting coronary heart disease
2. Diabetes appears to increase risk of death for patients with acute coronary syndromes
3. Treating depression may improve recovery of heart rate variability following coronary syndromes
4. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
5. Study Links Coronary Disease, Colon Cancer
6. Coronary Disease Might Toughen Up Heart
7. Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
8. Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System
9. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
10. Coronary Artery Calcium May Raise Womens Heart Risk
11. Abdominal Fat Tied to High Risk for Coronary Trouble
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Coronary Disease Dulls Cognitive Skills
Coronary Disease Dulls Cognitive Skills
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...have long suspected that sunlight has powerful -- ...endency to develop // a variety of diseases. The b... skin cancer. However, many suspect sunshine can h...n affect susceptibility to a variety of everyday v...
...al cancer is the second leading cause of cancer de...en detected at advanced stages. // Screening reduc...e more curable. A new study shows primary care pr...nts for colorectal cancer. Researchers attribute t...
... a recent study , Asian investigators suggest phys...because of its adverse effects.// A therapy routi... lung disease may result in slower neuromotor and ...ious research shows dexamethasone, a drug known as...
...arch shows scientific evidence that mental stress ...hmias are disturbances // in normal heart rhythm. ... while patients were under mental and physical str...risk for arrhythmias and healthy patients. For the...
Other Medicine News:Health News:Soaking In The Sun May Give You More Than Just a Tan 2
(Date:9/4/2008)...wswire/ -- Southern Research Institute,today annou...has selected,the organization to participate in th...n Center Network (MLPCN). The MLPCN -- a collabora...Libraries Program which is,designed to benefit hum...an,genome and validate future targets for drug dis...
(Date:9/4/2008)...4 /- Axentis Pharma AG has,initiated ...d tolerability,of a new therapeutic formulation fo...ystic fibrosis patients. The new formulation allow... directly to the site of,infection. The forthcomin...rent doses of the new drug. Initial results are ex...
(Date:9/4/2008)... antiviral activity and favorable safety ... Sept. 4 /- Idenix,Pharmace...l company engaged,in the discovery and development...er infectious diseases, today announced that it ha...IDX899, a non-nucleoside reverse,transcriptase inh...
(Date:9/4/2008)...edule with Two Abstracts Accepted for Presenta...2008, BRIDGEWATER, N.J., Sept. 4 /- ...ceutical company focused on the treatment of,cardi...he appointment of,Peter L. Garrambone, Jr. to the ... career includes more than 50 pharmaceutical,trans...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30 2008 4886 1Bypassing the insulin highway 3061 1FDA Examines Quality of Life for LASIK Patients 17784 1FDA Examines Quality of Life for LASIK Patients 17784 2FDA Examines Quality of Life for LASIK Patients 17784 3Engaging Health Care Consumers Online is Top Priority 17780 1Engaging Health Care Consumers Online is Top Priority 17780 2Engaging Health Care Consumers Online is Top Priority 17780 3
...eet Primary Endpoint of Improvement in Overall,Sur...re-FirstCall/ --,Allos Therapeutics, Inc. today an...s pivotal Phase 3 study of Efaproxyn ,(efaproxiral...en,with brain metastases originating from breast c...point of demonstrating a,statistically significant...
... 20, 2007 /PRNewswire-FirstCall/ -- Anadys,Pharmac...tted to,the discovery, development and commerciali...atitis and cancer, announced today that it,has nom...ent as an,orally-administered direct antiviral for...infection. , "We have identified a small-molecule,...
Other Medicine Technology:Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 2Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 3Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 4Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 6Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 2Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 3Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 4
The Infinity™ ALT single liquid stable reagent is intended for the in vitro quantitative determination of ALT in serum. , Infinity™ ALT reagent patented formulation not only provides ex
... analyzer. It is designed with the customer's anal...types of clinical chemistry tests, specific protei...tests, electrolytes and other user-definable appli...uitable for specialized chemistry applications out...
Inquire
ISI offers instrument cleaning brushes in a variety of lengths, diameters and composition. The long, thin brushes are perfect for cannulas and tubing. The smallest brushes are the answer for micros.
Medicine Products: